October 2021 Publications
- 100 years of Bacillus Calmette-Guérin immunotherapy: from cattle to COVID-19. Lobo N, Brooks NA, Zlotta AR, Cirillo JD, Boorjian S, Black PC, Meeks JJ, Bivalacqua TJ, Gontero P, Steinberg GD, McConkey D, Babjuk M, Alfred Witjes J, Kamat AM. Nat Rev Urol. 2021 Oct. doi: 10.1038/s41585-021-00481-1. Epub 2021 Jun 15.
- BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial. Glynn JR, Fielding K, Mzembe T, Sichali L, Banda L, McLean E, Kanjala C, Crampin AC, Ponnighaus JM, Warndorff DK, Fine PEM; Karonga Prevention Trial Group. Lancet Glob Health. 2021 Oct. doi: 10.1016/S2214-109X(21)00309-0.
- Computational identification and characterization of antigenic properties of Rv3899c of Mycobacterium tuberculosis and its interaction with human leukocyte antigen (HLA). Das R, Eniyan K, Bajpai U. Immunogenetics. 2021 Oct. doi: 10.1007/s00251-021-01220-x. Epub 2021 Jul 6.
- Proline-Glutamate/Proline-Proline-Glutamate (PE/PPE) proteins of Mycobacterium tuberculosis: The multifaceted immune-modulators. Medha, Sharma S, Sharma M. Acta Trop. 2021 Oct. doi: 10.1016/j.actatropica.2021.106035. Epub 2021 Jul 3.
- Albumin fusion with granulocyte-macrophage colony-stimulating factor acts as an immunotherapy against chronic tuberculosis. Chuang YM, He L, Pinn ML, Tsai YC, Cheng MA, Farmer E, Karakousis PC, Hung CF. Cell Mol Immunol. 2021 Oct. doi: 10.1038/s41423-020-0439-2. Epub 2020 May 7.
- A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line anti-tuberculosis regimen. Chiwala G, Liu Z, Mugweru JN, Wang B, Khan SA, Bate PNN, Yusuf B, Hameed HMA, Fang C, Tan Y, Guan P, Hu J, Tan S, Liu J, Zhong N, Zhang T. Biomed Pharmacother. 2021 Oct. doi: 10.1016/j.biopha.2021.112047. Epub 2021 Aug 21.
- Immunoinformatics analysis of antigenic epitopes and designing of a multi-epitope peptide vaccine from putative nitro-reductases of Mycobacterium tuberculosis DosR. Shiraz M, Lata S, Kumar P, Shankar UN, Akif M. Infect Genet Evol. 2021 Oct. doi: 10.1016/j.meegid.2021.105017. Epub 2021 Jul 28.
- T helper type 1 biased immune responses by PPE17 loaded core-shell alginate-chitosan nanoparticles after subcutaneous and intranasal administration. Najafi A, Ghazvini K, Sankian M, Gholami L, Amini Y, Zare S, Khademi F, Tafaghodi M. Life Sci. 2021 Oct 1. Epub 2021 Jul 9.
- Antibodies: what makes us stronger. Freund NT. Hum Vaccin Immunother. 2021 Oct 3. doi: 10.1080/21645515.2021.1929034. Epub 2021 May 25.
- Particle Dynamics and Bioaerosol Viability of Aerosolized Bacillus Calmette-Guerin Vaccine Using Jet and Vibrating Mesh Clinical Nebulizers. Redmann RK, Kaushal D, Golden N, Threeton B, Killeen SZ, Kuehl PJ, Roy CJ. J Aerosol Med Pulm Drug Deliv. 2021 Oct 6. doi: 10.1089/jamp.2021.0030. Online ahead of print.
- Pathogenic Effects of M. tuberculosis-Specific Proteins ESAT-6 and CFP-10 in Macrophage Culture and in 3D-Granulemogenesis Model In Vitro. Belogorodtsev SN, Nemkova EK, Stavitskaya NV, Schwartz YS. Bull Exp Biol Med. 2021 Oct 7. doi: 10.1007/s10517-021-05288-z. Online ahead of print.
- Development of a bivalent conjugate vaccine candidate against rotaviral diarrhea and tuberculosis using polysaccharide from Mycobacterium tuberculosis conjugated to deltaVP8* protein from rotavirus. Park WJ, Yoon YK, Kim Y, Park JS, Pansuriya R, Cho SN, Seok YJ, Ravi G. Vaccine. 2021 Oct 9. doi: 10.1016/j.vaccine.2021.09.067. Online ahead of print.
- Comparative transcriptomic analysis of THP-1-derived macrophages infected with Mycobacterium tuberculosis H37Rv, H37Ra and BCG. Pu W, Zhao C, Wazir J, Su Z, Niu M, Song S, Wei L, Li L, Zhang X, Shi X, Wang H. J Cell Mol Med. 2021 Oct 10. doi: 10.1111/jcmm.16980. Online ahead of print.
- Recent developments in systems biology and genetic engineering toward design of vaccines for TB.Singh Y, Beamer G, Sun X, Shukla P. Crit Rev Biotechnol. 2021 Oct 12:1-16. doi: 10.1080/07388551.2021.1951649. Online ahead of print.
- CD8 T Cell Vaccines and a Cytomegalovirus-Based Vector Approach. Šustić M, Cokarić Brdovčak M, Krmpotić A, Jonjić S. Life (Basel). 2021 Oct 15. doi: 10.3390/life11101097.
- In silico comparisons of lipid-related genes between Mycobacterium tuberculosis and BCG vaccine strains. Sarno A, Bitencourt J, Queiroz A, Arruda S. Genet Mol Biol. 2021 Oct 22. doi: 10.1590/1678-4685-GMB-2021-0024.
- Construction and immunogenicity of a T cell epitope-based subunit vaccine candidate against Mycobacterium tuberculosis. Fan X, Li X, Wan K, Zhao X, Deng Y, Chen Z, Luan X, Lu S, Liu H. Vaccine. 2021 Oct 23:S0264-410X(21)01354-2. doi: 10.1016/j.vaccine.2021.10.034.
- Analysis of Factors Influencing Multidrug-Resistant Tuberculosis and Validation of Whole-Genome Sequencing in Children with Drug-Resistant Tuberculosis. Zhang Y, Zhao R, Zhang Z, Liu Q, Zhang A, Ren Q, Li S, Long X, Xu H. Infect Drug Resist. 2021 Oct 24. doi: 10.2147/IDR.S331890.
- Deletion of BCG_2432c from the Bacillus Calmette-Guerin vaccine enhances autophagy-mediated immunity against tuberculosis. Wu Y, Tian M, Zhang Y, Peng H, Lei Q, Yuan X, Liu S, Xiong Y, Lin X, Jo-Lewis BN, Yao Z, Fu H, Fan X. Allergy. 2021 Oct 27. doi: 10.1111/all.15158. Online ahead of print.
- Development of a bivalent conjugate vaccine candidate against rotaviral diarrhea and tuberculosis using polysaccharide from Mycobacterium tuberculosis conjugated to deltaVP8* protein from rotavirus. Park WJ, Yoon YK, Kim Y, Park JS, Pansuriya R, Cho SN, Seok YJ, Ganapathy R. Vaccine. 2021 Oct 29. doi: 10.1016/j.vaccine.2021.09.067. Epub 2021 Oct 9.
- Development of a Multiplex Real-Time PCR Assay for Mycobacterium bovis BCG and Validation in a Clinical Laboratory. Duffy SC, Venkatesan M, Chothe S, Poojary I, Verghese VP, Kapur V, Behr MA, Michael JS.Microbiol Spectr. 2021 Oct 31. doi: 10.1128/Spectrum.01098-21. Epub 2021 Sep 8.